Actimis Pharmaceuticals Lands $9,600,000 New Round

  • Feed Type
  • Date
  • Company Name
    Actimis Pharmaceuticals
  • Mailing Address
    10835 Road To The Cure San Diego, CA 92121
  • Company Description
    Actimis Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused exclusively on the development and commercialization of small molecule therapeutics for severe respiratory, inflammatory and autoimmune diseases such as asthma, chronic obstructive pulmonary disease (COPD), inflammatory dermatoses, inflammatory bowel disease and rheumatoid arthritis.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Sanderling Ventures
  • Venture Investor

Trending on Xconomy